PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-08
DOI
10.1038/s41419-020-2700-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas
- (2015) S. Kreuz et al. Molecular Cancer
- Abstract 5194: Pim2 is required for maintaining Multiple Myeloma cell proliferation through modulating mTORC1 pathway.
- (2014) Jing Lu et al. CANCER RESEARCH
- Allele-Specific Imbalance of Oxidative Stress-Induced Growth Inhibitor 1 Associates With Progression of Hepatocellular Carcinoma
- (2014) Ming Liu et al. GASTROENTEROLOGY
- Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
- (2014) Yuki Kagoya et al. JOURNAL OF CLINICAL INVESTIGATION
- PIM2 Kinase Is Induced by Cisplatin in Ovarian Cancer Cells and Limits Drug Efficacy
- (2014) Daniele Musiani et al. JOURNAL OF PROTEOME RESEARCH
- PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
- (2014) Austin N. Kirschner et al. JNCI-Journal of the National Cancer Institute
- Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
- (2014) M Hiasa et al. LEUKEMIA
- PhosphoNetworks: a database for human phosphorylation networks
- (2013) J. Hu et al. BIOINFORMATICS
- AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
- (2013) E. K. Keeton et al. BLOOD
- Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation
- (2013) J. Lu et al. BLOOD
- Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling
- (2013) Lulu Liu et al. HEPATOLOGY
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
- (2013) Leilei Chen et al. NATURE MEDICINE
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in Mice
- (2012) Yan Li et al. GASTROENTEROLOGY
- The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
- (2011) J Asano et al. LEUKEMIA
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma
- (2010) Li Fu et al. HEPATOLOGY
- Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway
- (2009) Ke Ren et al. PATHOLOGY & ONCOLOGY RESEARCH
- PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling
- (2009) Kushagra Bansal et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started